Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 [Anti-cholinesterase activity of huperzine A].

× No keyword cloud information.

13 in total

1. Enantiomer effects of huperzine A on the aryl acylamidase activity of human cholinesterases.

Authors: Sultan Darvesh; Ryan Walsh; Earl Martin
Journal: Cell Mol Neurobiol Date: 2003-02 Impact factor: 5.046

2. Comparison of the efficacy of four cholinesterase inhibitors in combination with memantine for the treatment of Alzheimer's disease.

Authors: Zi-Qiang Shao
Journal: Int J Clin Exp Med Date: 2015-02-15

3. Mapping of the interaction sites of galanthamine: a quantitative analysis through pairwise potentials and quantum chemistry.

Authors: Nicolas Galland; Soleymane Kone; Jean-Yves Le Questel
Journal: J Comput Aided Mol Des Date: 2012-09-13 Impact factor: 3.686

4. A phase II trial of huperzine A in mild to moderate Alzheimer disease.

Authors: M S Rafii; S Walsh; J T Little; K Behan; B Reynolds; C Ward; S Jin; R Thomas; P S Aisen
Journal: Neurology Date: 2011-04-19 Impact factor: 9.910

5. In vitro inhibitory profile of NDGA against AChE and its in silico structural modifications based on ADME profile.

Authors: Chandran Remya; Kalarickal Vijayan Dileep; Ignatius Tintu; Elessery Jayadevi Variyar; Chittalakkottu Sadasivan
Journal: J Mol Model Date: 2012-11-16 Impact factor: 1.810

Review 6. Acetylcholinesterase: a multifaceted target for structure-based drug design of anticholinesterase agents for the treatment of Alzheimer's disease.

Authors: Harry M Greenblatt; Hay Dvir; Israel Silman; Joel L Sussman
Journal: J Mol Neurosci Date: 2003 Impact factor: 2.866

[Anti-cholinesterase activity of huperzine A].

1. Enantiomer effects of huperzine A on the aryl acylamidase activity of human cholinesterases.

2. Comparison of the efficacy of four cholinesterase inhibitors in combination with memantine for the treatment of Alzheimer's disease.

3. Mapping of the interaction sites of galanthamine: a quantitative analysis through pairwise potentials and quantum chemistry.

4. A phase II trial of huperzine A in mild to moderate Alzheimer disease.

5. In vitro inhibitory profile of NDGA against AChE and its in silico structural modifications based on ADME profile.

Review 6. Acetylcholinesterase: a multifaceted target for structure-based drug design of anticholinesterase agents for the treatment of Alzheimer's disease.

Review 7. Treating senile dementia with traditional Chinese medicine.

Review 8. Proteomics in Traditional Chinese Medicine with an Emphasis on Alzheimer's Disease.

Review 9. Huperzine A for Alzheimer's disease: a systematic review and meta-analysis of randomized clinical trials.

Review 10. Huperzine A: Is it an Effective Disease-Modifying Drug for Alzheimer's Disease?